Megalin and cubilin in the human gallbladder epithelium.
Although the role of cholesterol absorption by the gallbladder epithelium in gallstone formation is well established, the exact process is poorly understood. Potential candidates for regulation of transepithelial cholesterol transport are suggested to be two large membrane multiple ligand receptors, megalin and cubilin. We studied the expression of these two proteins in both acalculous and calculous human gallbladder epithelia. Adult human gallbladder tissues were received from 21 patients (9 men, 12 women) who had undergone cholecystectomy. The patients were divided into two groups: group A (calculous gallbladder group; 5 men, 6 women; mean age 64.4 +/- 11.1 years) with cholelithiasis, and group B (acalculous gallbladder group; 4 men, 6 women; mean age 55.3 +/- 16.1 years). In the gallbladder tissues megalin and cubilin expression was studied by immunohistochemistry and conventional RT-PCR, and gene expression levels were estimated by real-time RT-PCR. Both megalin and cubilin gene transcripts were found in total RNA preparations from acalculous gallbladder. In contrast, in preparations from calculous gallbladder, none or only one of the proteins was detected. Immunoreactive proteins were detected in the simple columnar acalculous gallbladder epithelium but not in the calculous gallbladder epithelium. Our results show different expression patterns of the two proteins in calculous gallbladders and acalculous gallbladders. In the latter both proteins are expressed, suggesting an association with gallstone formation and implying a putative role of the two proteins in cholesterol endocytosis. In other words, the presence of both proteins may be essential for the prevention of stone formation.
Tsaroucha
Alexandra K
AK
2nd Department of Surgery, Medical School, Democritus University of Thrace, Alexandroupolis, Greece. tsihrin@otenet.gr
Chatzaki
Ekaterini
E
Lambropoulou
Maria
M
Despoudi
Kaliopi
K
Laftsidis
Prodromos
P
Charsou
Chara
C
Polychronidis
Alexandros
A
Papadopoulos
Nikolaos
N
Simopoulos
Constantinos E
CE
D000368:Aged; D001483:Base Sequence; D016022:Case-Control Studies; D002769:Cholelithiasis / Q000378:metabolism; D017931:DNA Primers; D004848:Epithelium / Q000378:metabolism; D005260:Female; D005704:Gallbladder / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D026561:Low Density Lipoprotein Receptor-Related Protein-2 / Q000235:genetics / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D012333:RNA, Messenger / Q000235:genetics; D011956:Receptors, Cell Surface / Q000235:genetics / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction
D017931:DNA Primers; D026561:Low Density Lipoprotein Receptor-Related Protein-2; D012333:RNA, Messenger; D011956:Receptors, Cell Surface; C029486:intrinsic factor-cobalamin receptor
Gut. 2003 Jul;52(7):1017-24
12801960
Mamm Genome. 1999 Nov;10(11):1070-4
10556425
J Hepatol. 2004 Aug;41(2):195-200
15288466
J Exp Med. 1983 Feb 1;157(2):667-86
6337231
J Exp Med. 1988 Jan 1;167(1):213-8
2891781
J Neurosci Res. 2006 Apr;83(5):864-73
16463279
Hepatology. 2002 Nov;36(5):1145-54
12395324
J Lipid Res. 1999 Nov;40(11):2080-90
10553011
Aliment Pharmacol Ther. 2000 May;14 Suppl 2:39-47
10903002
Methods. 2001 Dec;25(4):402-8
11846609
Am J Physiol Endocrinol Metab. 2001 Nov;281(5):E900-7
11595644
J Postgrad Med. 2002 Apr-Jun;48(2):149-52
12215703
J Clin Invest. 1968 May;47(5):1043-52
5645851
J Lipid Res. 1999 Nov;40(11):2066-79
10553010
J Mol Med (Berl). 2001 May;79(4):161-7
11409706
Annu Rev Nutr. 2001;21:407-28
11375443
Lancet. 2006 Jul 15;368(9531):230-9
16844493
Hepatology. 2007 Sep;46(3):793-801
17626266
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12491-6
11606717
J Lipid Res. 2004 Dec;45(12):2185-98
15375181
Physiol Genomics. 2003 Aug 15;14(3):225-39
12837957
Mol Reprod Dev. 2003 Feb;64(2):129-35
12506344